Kinetic evidence for isomerization of the dopamine receptor-raclopride complex

被引:30
作者
Lepiku, M
Rinken, A
Jarv, J
Fuxe, K
机构
[1] TARTU STATE UNIV,INST CHEM PHYS,EE-2400 TARTU,ESTONIA
[2] KAROLINSKA INST,DEPT NEUROSCI,S-17177 STOCKHOLM,SWEDEN
[3] UNIV UPPSALA,DEPT MED & PHYSIOL CHEM,S-75123 UPPSALA,SWEDEN
关键词
D O I
10.1016/0197-0186(95)00123-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The binding kinetics of the specific dopamine D-2 antagonist [H-3]raclopride to dopamine D-2 receptors in rat neostriatum were studied. The pseudo-first-order rate constants of [H-3]raclopride binding with these membranes revealed a hyperbolic dependence upon the antagonist concentration, indicating that the reaction had at least two consecutive and kinetically distinguishable steps. The first step was fast binding equilibrium, characterized by the dissociation constant K-A = 12+/-3 nM. The following step corresponded to a slow isomerization of the receptor-antagonist complex, characterized by the isomerization equilibrium constant K-i = 0.11. The dissociation constant K-d = 1.3 nM, calculated from these kinetic data, was similar to K-d = 2.4 nM, determined from equilibrium binding isotherm for the radioligand. Implications of the complex reaction mechanism on dopamine D-2 receptor assay by [H-3]raclopride were discussed. Copyright (C) 1996 Elsevier Science Ltd.
引用
收藏
页码:591 / 595
页数:5
相关论文
共 20 条
[1]   ANTI-PSYCHOTIC DRUG-ACTION - CLINICAL, BIOCHEMICAL, AND PHARMACOLOGICAL EVIDENCE FOR SITE SPECIFICITY OF ACTION [J].
BORISON, RL ;
HITRI, A ;
BLOWERS, AJ ;
DIAMOND, BI .
CLINICAL NEUROPHARMACOLOGY, 1983, 6 (02) :137-150
[2]  
Changeux J.-P., 1990, FIDIA RES F NEUROSCI, P21
[3]  
CHATTERJEE TK, 1988, MOL PHARMACOL, V33, P402
[4]  
DEWAR KM, 1989, J PHARMACOL EXP THER, V250, P696
[5]  
DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653
[6]   2-STEP ISOMERIZATION OF QUINUCLIDINYL BENZILATE MUSCARINIC RECEPTOR COMPLEX [J].
ELLER, M ;
JARV, J .
NEUROCHEMISTRY INTERNATIONAL, 1988, 12 (03) :285-289
[7]   GUANINE-NUCLEOTIDE REGULATION OF AGONIST INTERACTIONS AT [H-3] SCH23390-LABELED D1 DOPAMINE-RECEPTORS IN RAT STRIATUM [J].
HESS, EJ ;
BATTAGLIA, G ;
NORMAN, AB ;
IORIO, LC ;
CREESE, I .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 121 (01) :31-38
[8]  
HULME EC, 1992, RECEPTOR LIGAND INTE, P63
[9]   KINETIC ASPECTS OF L-QUINUCLIDINYL BENZILATE INTERACTION WITH MUSCARINIC RECEPTOR [J].
JARV, J ;
ELLER, M .
NEUROCHEMISTRY INTERNATIONAL, 1988, 13 (04) :419-428
[10]  
JARV J, 1979, J BIOL CHEM, V254, P5595